This is a Scorecard review, revisiting a past LF0 research call against what actually happened.
Ticker: BSX Rating: Buy Published: 2026-06-14 Checkpoint: 2026-10-14 Entry price: $46.76 Latest price: $43.00 as of 2026-10-14 Stock return since entry: -8.0% Signal return: -8.0% Verdict: Incorrect so far
This is the 4-month checkpoint for this call. LF0 publishes monthly Scorecard updates through month 6, using the closest available daily close on or before the checkpoint date.
Read the original LF0 analysis
What I Said
I argued that Boston Scientific was a good business, but that the stock already reflected a lot of that quality at roughly 13.4x EV/EBITDA. My main concern was the balance sheet: I highlighted $12.6B of debt ahead of the Penumbra integration and said I would only get more constructive if leverage stayed below 2.5x net debt/EBITDA while growth stayed strong.
Peer Comparison
| Company | Return Since Entry |
|---|---|
| BSX (this call) | -8.0% |
| ABT | +19.9% |
| EW | +0.4% |
| MDT | +19.9% |
| SYK | -3.8% |
| ZBH | +8.2% |
Why It’s Working (Or Not)
Over this tracking window, a long position would have lost about 8.0%, which means the Buy call has not worked. The stock has moved lower while the peer group has been mixed to higher overall, with several comparables posting solid gains, so BSX has not shown the relative strength I was looking for. That lines up with my original caution that the valuation already assumed a lot and that the added debt burden could make the setup less forgiving. The specific test I set out — growth and leverage staying comfortably supportive — has not been validated by the price action I was willing to pay for.
The June 2026 Cohort
Other directional calls published the same month:
| Ticker | Rating | Entry | Latest | Stock Return | Signal Return | Verdict |
|---|---|---|---|---|---|---|
| SKYH | Sell | $9.37 | $9.10 | -2.9% | +2.9% | Correct so far |
| SOUN | Sell | $7.33 | $4.72 | -35.6% | +35.6% | Correct so far |
| AEHR | Sell | $115.30 | $60.60 | -47.4% | +47.4% | Correct so far |
| BW | Sell | $17.76 | $4.62 | -74.0% | +74.0% | Correct so far |
Sector Scorecard: Healthcare
How are our Healthcare calls doing overall, and where does BSX sit among them?
| Peer call | Rating | Published | Signal return |
|---|---|---|---|
| CUE | Sell | 2026-09-02 | +38.0% |
| OWLT | Sell | 2026-08-12 | +29.3% |
| STXS | Sell | 2026-08-16 | +27.3% |
| WGS | Sell | 2026-08-09 | +18.3% |
| NUTX | Buy | 2026-08-16 | -1.2% |
| SDGR | Sell | 2026-08-17 | -29.9% |
Across sectors, Industrials led our directional calls with a 92% hit rate and +23.7% average signal return, while Technology also posted a 92% hit rate with +15.7% and the largest call count at 24. Communication Services was perfect at 100% with +17.4%, but Basic Materials and Consumer Cyclical were thin at 3 calls each, so we note those samples are small even though both showed 100% hit rates and +16.8% and +13.7% average returns, respectively. Healthcare was middling at 57% and +11.0%, with CUE at +38.0% as the best call and SDGR at -29.9% as the worst, while Energy lagged at 50% and +2.5%.
Sector League Table
| Sector | Calls | Hit rate | Avg signal return | Best | Worst |
|---|---|---|---|---|---|
| Industrials | 13 | 92% | +23.7% | BW +74.0% | CAR -12.3% |
| Communication Services | 5 | 100% | +17.4% | SPHR +29.7% | CHTR +6.3% |
| Utilities | 3 | 33% | +17.1% | FLNC +59.8% | TLN -6.9% |
| Basic Materials | 3 | 100% | +16.8% | LAR +30.9% | GFI +5.4% |
| Financial Services | 4 | 75% | +15.9% | MARA +35.5% | BMNR -22.1% |
| Technology | 24 | 92% | +15.7% | CIFR +58.9% | NLST -135.2% |
| Consumer Cyclical | 3 | 100% | +13.7% | PENN +19.5% | RRGB +7.4% |
| Healthcare | 7 | 57% | +11.0% | CUE +38.0% | SDGR -29.9% |
| Energy | 4 | 50% | +2.5% | TPL +14.0% | VNOM -8.0% |
| Real Estate* | 2 | 100% | +18.9% | SRG +34.8% | SKYH +2.9% |
| Unclassified* | 2 | 50% | +7.4% | NXE +19.5% | FISV -4.8% |
\* Fewer than 3 calls: not ranked.
Sector by Publish Month
| Sector | Jun 2026 | Jul 2026 | Aug 2026 | Sep 2026 | Oct 2026 |
|---|---|---|---|---|---|
| Technology | +41.5% (2) | +1.0% (7) | +18.8% (3) | +20.2% (6) | +18.3% (6) |
| Industrials | +74.0% (1) | +35.1% (5) | +7.2% (2) | +2.4% (3) | +18.4% (2) |
| Healthcare | -5.1% (1) | — | +8.8% (5) | +38.0% (1) | — |
| Communication Services | — | +17.1% (1) | +19.5% (2) | +6.3% (1) | +24.6% (1) |
| Energy | — | +14.0% (1) | -8.0% (1) | -2.3% (1) | +6.4% (1) |
| Financial Services | — | +14.8% (3) | — | — | +19.0% (1) |
| Basic Materials | — | +14.3% (1) | — | +30.9% (1) | +5.4% (1) |
| Utilities | — | +59.8% (1) | -1.6% (1) | — | -6.9% (1) |
| Consumer Cyclical | — | — | +13.7% (3) | — | — |
| Real Estate | +2.9% (1) | — | +34.8% (1) | — | — |
| Unclassified | — | — | +19.5% (1) | — | -4.8% (1) |
Each cell: average signal return to date of the calls published that month (calls in brackets). Signal return is direction-adjusted, so a positive number means our call is right.
Live LF0 scorecard: The Scorecard | Research Performance dashboard
Past performance does not guarantee future results. Nothing here is investment advice or a recommendation to buy or sell securities. Returns use LF0’s daily-close scorecard methodology.
Leave a Comment